**Core Concept**
Decreased vascularity of fibroid refers to a reduction in blood flow to uterine leiomyomas, which are benign tumors of the uterus. This phenomenon is crucial in the management of fibroids, as it can lead to a decrease in their size and symptoms. The drugs that induce this effect are typically used to shrink fibroids before surgery or to treat symptoms associated with their growth.

**Why the Correct Answer is Right**
GnRH agonists, such as leuprolide, work by downregulating gonadotropin-releasing hormone receptors in the pituitary gland, leading to a decrease in estrogen levels. Estrogen is a key factor in the growth of fibroids, and its reduction results in decreased vascularity and subsequent shrinkage of the tumors. Danazol, a synthetic testosterone derivative, has a similar effect on fibroid vascularity by inducing a hypoestrogenic state. Mifepristone, a progesterone receptor antagonist, also contributes to decreased vascularity by inhibiting the growth-promoting effects of progesterone on fibroids. The combination of these drugs can synergistically reduce fibroid vascularity, making them more suitable for surgical removal.

**Why Each Wrong Option is Incorrect**
**Option A:** GnRH agonists do indeed decrease vascularity of fibroids, but this is not a unique property of GnRH agonists alone.

**Option B:** Danazol does decrease vascularity of fibroids, but it is not the only option.

**Option C:** Mifepristone also decreases vascularity of fibroids, but this is not a comprehensive answer.

**Clinical Pearl / High-Yield Fact**
When treating fibroids, it's essential to understand that decreased vascularity is a key factor in their shrinkage. This knowledge can help clinicians choose the most effective treatment options and predict patient outcomes.

**Correct Answer Line**
✓ Correct Answer: D. All